Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: Report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)

Diagnostic Microbiology and Infectious Disease

Volumn 45, Issue 4, 2003, Pages 287-293

  Rennie, Robert P ^a   Jones, Ronald N ^b   Mutnick, Alan H ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b JMI LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; EVERNIMICIN; GARENOXACIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; OXACILLIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANADA; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS; ENZYME SYNTHESIS; ESCHERICHIA COLI; HEALTH CENTER; HEALTH PROGRAM; HEALTH SURVEY; HOSPITALIZATION; HUMAN; MEDICAL DECISION MAKING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SKIN INFECTION; SOFT TISSUE INFECTION; STANDARD; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 0038702328     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00543-6     Document Type: Article

References (13)

1. Critchley I.A., Sahm D.F., Thornsberry C., Blosser-Middleton R.S., Jones M.E., Karlowsky J.A. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections United States LIBRA surveillance data from 1999 . Diagn Microbiol Infect Dis. 42:2002;129-135.
2. Doern G.V., Jones R.N., Pfaller M.A., Kugler K.C., Beach M.L. Bacterial pathogens isolated from patients with skin and soft tissue infections Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Survellance Program (United States and Canada, 1997) . Diagn Microbiol Infect Dis. 34:1999;65-72.
3. Falagas M.E., Barefoot L., Griffith J., Ruthazar R., Snydman D.R. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur J Clin Microbiol Infect Dis. 15:1996;913-921.
4. Fluit A.C., Schmitz F.J., Verhoef J. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients. Eur J Clin Microbiol Infect Dis. 20:2001;188-191.
5. Gales A.C., Jones R.N., Pfaller M.A., Gordon K.A., Sader H.S. Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals results from the SENTRY Antimicrobial Surveillance Program, 1997-98. SENTRY Study Group . Int J Infect Dis. 4:2000;75-84.
6. Jones M.E., Schmitz F.J., Fluit A.C., Acar J., Gupta R., Verhoef J. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an international surveillance programme. SENTRY Study Group. Eur J Clin Microbiol Infect Dis. 18:1999;403-408.
7. Jones R.N. Resistance patterns among nosocomial pathogens trends over the past few years . Chest. 119:(Suppl):2001;397S-404S.
8. Karlowsky J.A., Zhanel G.G., Hoban D.J. Vancomycin-resistant enterococci (VRE) colonization of high-risk patients in tertiary care Canadian hospitals. Canadian VRE Surveillance Group. Diagn Microbiol Infect Dis. 35:1999;1-7.
9. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-fifth edition. 2000;NCCLS, Wayne PA.
10. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement (M100-S12). 2002;NCCLS, Wayne PA.
11. Sader H.S., Sampaio J.L., Zoccoli C., Jones R.N. Results of the 1997 SENTRY Antimicrobial Surveillance Program in three Brazilian medical centers. Brazilian J Infect Dis. 3:1999;63-79.
12. Sader H.S., Gales A.C., Pfaller M.A., Mendes R.E., Zoccoli C., Barth A., Jones R.N. Pathogen frequency and resistance patterns in Brazilian hospitals summary of results from three years of the SENTRY Antimicrobial Surveillance Program . Brazilian J Infect Dis. 5:2001;200-214.
13. Shmuely H., Pitlik S., Drucker M., Samra Z., Konisberger H., Leibovici L. Prediction of mortality in patients with bacteremia The importance of pre-existing renal insufficiency . Renal Failure. 22:2000;99-108.